Skip to main content
main-content

Medicine Matters branded image Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in rheumatology

Anifrolumab for the treatment of lupus

Anifrolumab for the treatment of lupus

Listen to expert perspective on the approval of anifrolumab and read about the importance of endpoints in lupus trials

JAK inhibitor safety

Safety snapshot: Upadacitinib in patients with PsA

Weigh up the safety data with summaries and expert discussion on the potential risks associated with JAK inhibitors.

News

Mediterranean diet may be beneficial for people with axSpA

Mediterranean diet

Improved adherence to a Mediterranean dietary pattern is associated with a reduction in disease activity among people with axial spondyloarthritis, indicate findings from an Italian observational study.

New additions to the Adis Journal Club

Drugs & Therapy Perspectives

Browse September's selection of peer-reviewed articles from the Adis journal portfolio. Curated by the editors and updated monthly. These papers highlight topical research and reviews for the benefit of Medicine Matters readers.

JAK inhibitor safety

Data summary and expert discussion on the potential risks associated with JAK inhibitors.

IN FOCUS | JAK inhibitors

02-09-2021 | JAK inhibitors | News

FDA requires boxed warning updates for JAK inhibitors

Click through for more information on this announcement

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

IN FOCUS | COVID-19 & rheumatic disease

16-09-2021 | COVID-19 | News

Low rates of breakthrough SARS-CoV-2 infection after vaccination in people with RMDs

Preliminary findings from two studies point to low overall rates of breakthrough COVID-19 following vaccination in people with rheumatic and musculoskeletal diseases.

COVID-19 vaccination in patients with rheumatic diseases

Get answers to key questions with recommendations from professional organizations

IN FOCUS | Inflammatory arthritis

14-09-2021 | Axial spondyloarthritis | News

Mediterranean diet may be beneficial for people with axSpA

Improved adherence to a Mediterranean dietary pattern is associated with a reduction in disease activity among people with axial spondyloarthritis, indicate findings from an Italian observational study.

Common scores used in rheumatology

An at-a-glance reference guide to the scores that are commonly used in clinical trials & daily rheumatology practice

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Podcasts

Interviews with expert rheumatologists on patient care

Image Credits